Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $50 | $9,088 | $8 | $9 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | $7 | $9,088 | $8 | $9 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| R&D Expenses | $50 | $464 | $290 | $254 |
| G&A Expenses | $159 | $69 | $65 | -$39 |
| SG&A Expenses | $29 | $110 | $103 | -$21 |
| Sales & Mktg Exp. | $32 | $41 | $37 | $18 |
| Other Operating Expenses | $0 | $175 | $22 | $175 |
| Operating Expenses | $79 | $749 | $415 | $408 |
| Operating Income | -$72 | $8,338 | -$407 | -$399 |
| % Margin | -145.9% | 91.7% | -5,030.1% | -4,409% |
| Other Income/Exp. Net | $95 | -$227 | $70 | $108 |
| Pre-Tax Income | -$367 | $8,111 | -$337 | -$292 |
| Tax Expense | $6 | $537 | -$1 | -$1 |
| Net Income | -$63 | $7,574 | -$335 | -$291 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS | -0.9 | 107.08 | -4.75 | -4.64 |
| % Growth | -100.8% | 2,354.3% | -2.4% | – |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| Weighted Avg Shares Out | 70 | 71 | 71 | 63 |
| Weighted Avg Shares Out Dil | 70 | 72 | 71 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $109 | $56 | $42 | $63 |
| Interest Expense | $7 | $7 | $8 | $8 |
| Depreciation & Amortization | $7 | $6 | $6 | $6 |
| EBITDA | -$353 | $8,125 | -$323 | -$277 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |